Molecular & Cellular Toxicology

The Korean Society of Toxicogenomics and Toxicoproteomics (대한독성유전 단백체학회)
권호 표지

Gene Expression Profile and Its Interpretation in Squamous Cell Lung Cancer

  • Published : 2006.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

95 squamous cell lung carcinoma samples (normal tissue: 40 samples, tumor: 55 samples) were analyzed with 8 K cDNA microarray. 1-way ANOVA test was employed to select differentially expressed genes in tumor with FDR<0.01. Among the selected 1,655 genes, final 212 genes were chosen according to the expression fold change and used for following analysis. The expression of up-regulated 64 genes was verified with Reverse Transcription PCR and 10 genes were identified as candidates for SCC markers. In our opinion, those candidates can be exploited as diagnostic or therapeutic purposes. Gene Ontology (GO) based analysis was performed using those 212 genes, and following categories were revealed as significant biological processes: Immune response (GO: 0006955), antigen processing (GO: 0030333), inflammatory response (GO: 0006954), Cell adhesion (GO: 0007155), and Epidermis differentiation (GO: 0008544). Gene set enrichment analysis (GSEA) also carried out on overall gene expression profile with 522 functional gene sets. Glycolysis, cell cycle, K-ras and amino acid biosynthesis related gene sets were most distinguished. These results are consistent with the known characteristics of SCC and may be interconnected to rapid cell proliferation. However, the unexpected results from ERK activation in squamous cell carcinoma gripped our attention, and further studies are under progress.

Keywords

References

  1. Hibi, K. et al. PGP9.5 as candidate tumor marker for non-small cell lung cancer. Am. J. Pathology 155, 711-715 (1999) https://doi.org/10.1016/S0002-9440(10)65169-3
  2. Brechot, J.M. et al. Diagnostic and prognostic value of Cyfra 21-1 compared with other tumor markers in patients with non-small cell lung cancer: a prospective study of 116 patients. Eur. J. Cancer 33, 385-391(1997) https://doi.org/10.1016/S0959-8049(97)89010-7
  3. Pastor, A. et al. Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis. Eur. Respir. J. 10, 603-609 (1997)
  4. Morita, S. et al. Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small cell lung cancer tissue: analysis by northern blotting and in situ hybridization. Int. J. Cancer 78, 286-292 (1999)
  5. Wang, T. et al. Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis. Oncogene 19, 1519-1528 (2000) https://doi.org/10.1038/sj.onc.1203457
  6. Petroziello, J. et al. Suppression subtractive hybridization and expression profiling identifies a unique setof genes overexpressed in non-small cell lung cancer. Oncogene 23, 7734-7745 (2004) https://doi.org/10.1038/sj.onc.1207921
  7. Heighway, J. et al. Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 21, 7749-7763 (2002). https://doi.org/10.1038/sj.onc.1205979
  8. Shaw, L.M. et al. Activation of phosphoinositide 3-OH kinase by the $\alpha6\beta4$ integrin promotes carcinoma invasion. Cell 91, 949-960 (1997) https://doi.org/10.1016/S0092-8674(00)80486-9
  9. Nikolopoulos, S.N. et al. Integrin $\beta4$ signaling promotes tumor angiogenesis. Cancer Cell 6, 471-483 (2004) https://doi.org/10.1016/j.ccr.2004.09.029
  10. Romain, S. et al. DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): association with flow cytometric s-phase fraction and relative prognostic importance in node-negative premenopausal patients. Int. J. Cancer 95, 56-61 (2001) https://doi.org/10.1002/1097-0215(20010120)95:1<56::AID-IJC1010>3.0.CO;2-3
  11. Oguri, T. et al. Increased expression of the MRP5 gene is associated with exposure to platinum drugs in lung cancer. Int. J. Cancer 86, 95-100 (2000) https://doi.org/10.1002/(SICI)1097-0215(20000401)86:1<95::AID-IJC15>3.0.CO;2-G
  12. Solmi, R. et al. Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR. Int. J. Oncology 25, 1049-1056 (2004)
  13. Vicent, S. et al. ERK1/2 is activated in non-small cell lung cancer and associated with advance tumours. Br. J. Cancer 90, 1047-1052 (2004) https://doi.org/10.1038/sj.bjc.6601644
  14. Yang, Y.H. et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15 (2002) https://doi.org/10.1093/nar/30.4.e15
  15. Gene Ontology Consortium. The Gene Ontology (GO) database and information resource. Nucleic Acids Res. 32, D258-D261 (2004) https://doi.org/10.1093/nar/gkh036
  16. Kanehisa, M. et al. From genomics to chemical genomics:new developments in KEGG. Nucleic Acids Res. 34, D354-D357 (2006) https://doi.org/10.1093/nar/gkj102
  17. Subramanian, A. et al. Gene set enrichment analysis:A knowledge-based approach for interpreting genome -wide expression profiles. Proc. Natl. Acad. Sci.U.S.A. 102, 15545-15550 (2005)
  18. Travazoie, S. et al. Systematic determination of genetic network architecture. Nat. Genet. 22, 281-285 (1999) https://doi.org/10.1038/10343